Novavax Investor Relations | Novavax
View our earnings and investor presentations, latest press releases and events. Novavax is a global biotechnology company with a proven vaccine technology, focused on developing our R&D assets and establishing partnerships to help protect health.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-03 | 23.531 |
| 2025-04 | 20.484 |
| 2025-05 | 22.319 |
| Source | Traffic Share |
|---|---|
| search | 45.21% |
| direct | 37.28% |
| referrals | 10.21% |
| social | 5.58% |
| paid referrals | 1.18% |
| 0.12% |
| Region | Percentage |
|---|---|
| United States | 47.76% |
| Japan | 36.80% |
| Australia | 5.19% |
| Canada | 4.64% |
| India | 2.48% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| novovax | 258 | 2,580 | $1.02 |
| novavax investor relations | 21 | 210 | $0.00 |
| novax news on 10/16/24 | 4 | 40 | $0.00 |
| novavax vaccine finder | 19 | 190 | $2.39 |
| novavax sk | 0 | 0 | $0.00 |